Virtu Financial’s Aethlon Medical AEMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Buy
+5,563
New +$57.6K ﹤0.01% 1328
2025
Q2
– Sell
-41
Closed -$6K – 1397
2025
Q1
$6K Sell
41
-194
-83% -$45.2K ﹤0.01% 1221
2024
Q4
$81K Buy
+235
New +$39.9K ﹤0.01% 1066
2023
Q3
– Sell
-5
Closed -$7K – 1232
2023
Q2
$7K Buy
+5
New +$7.32K ﹤0.01% 1378
2023
Q1
– Sell
-15
Closed -$17K – 1481
2022
Q4
$17K Buy
+15
New +$27.3K ﹤0.01% 1294
2021
Q2
– Sell
-5
Closed -$40K – 1455
2021
Q1
$40K Buy
+5
New +$48.1K ﹤0.01% 1456
2019
Q3
– Hold
0
– -$11K – 1393
2019
Q2
– Hold
0
– – – 1381
2019
Q1
– Hold
0
– – – 1341
2018
Q4
– Hold
0
– -$13K – 1514
2018
Q3
– Sell
-1
Closed -$70K – 1432
2018
Q2
$47K Hold
1
– – ﹤0.01% 1763
2018
Q1
$46K Buy
+1
New +$88.4K ﹤0.01% 1732
2017
Q4
– Sell
-1
Closed -$57K – 2312
2017
Q3
$57K Buy
+1
New +$108K ﹤0.01% 2206

Other funds holding AEMD

Virtu Financial's AEMD Position: Q2 2026 in Review

Virtu Financial opened a new position in Aethlon Medical (AEMD) in Q2 2026: 5,563 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #1328 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AEMD as recently as Q1 2025.

Virtu Financial first reported a position in AEMD in Q3 2017 and has held it in 9 quarters since. The position peaked at $81K in Q4 2024. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

  • Virtu Financial held 5,563 shares of Aethlon Medical worth $23K as of Q2 2026.
  • Aethlon Medical was a new Virtu Financial position in Q2 2026.
  • Aethlon Medical made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1328 holding.
  • Virtu Financial first reported a position in Aethlon Medical in Q3 2017 and has held it in 9 quarters since.
  • Virtu Financial's Aethlon Medical position peaked at $81K in Q4 2024.
  • 15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.